Mark James Litton Insider Profile

4 Followers
Mark James Litton, CBO at Alder Biopharmaceuticals, holds 180.19K shares in Alder Biopharmaceuticals (Ticker: ALDR), holds ― shares in Alpine Immune Sciences (Ticker: ALPN), holds 83.25K shares in Athira Pharma (Ticker: ATHA).
tipranks
Mark James Litton

Mark James Litton
Alder Biopharmaceuticals (ALDR)
CBO

Ranked #63,149 out of 78,624 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

-24.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
0.00%
A breakdown of Mark James Litton's holdings

Insider Roles

Athira Pharma
(ATHA)
Chief Operating Officer
Alpine Immune Sciences
(ALPN)
President and Chief Operating Officer
Roles that Mark James Litton holds in companies

Most Profitable Insider Trade

Stock:
Alder Biopharmaceuticals
(ALDR)
Rating:Informative Sell
Date:Jun 08, 2015 - Jun 08, 2016
Return:+33.00%
The most profitable trade made by Mark James Litton

Mark James Litton's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ALDR
Alder Biopharmaceuticals
Jun 05, 2018
Uninformative Sell
405.37K
$3.40M
Alpine Immune Sciences
President and Chief Operating Officer
Athira Pharma
Sep 22, 2020
Chief Operating Officer
Uninformative Buy
$2.00M
List of latest transactions for each holding click on a transaction to see Mark James Litton's performance on stock

Mark James Litton insider profile FAQ

What is the percentage of profitable transactions made by Mark James Litton?
The percentage of profitable transactions made by Mark James Litton is 50%.
    What is the average return per transaction made by Mark James Litton?
    The average return per transaction made by Mark James Litton is -24.20%.
      What stocks does Mark James Litton hold?
      Mark James Litton holds: ALDR, ALPN, ATHA stocks.
        What was Mark James Litton’s latest transaction?
        Mark James Litton latest transaction was an Uninformative Sell of $405.37K.
          What was Mark James Litton's most profitable transaction?
          Mark James Litton’s most profitable transaction was an Informative Sell of ALDR stock on June 8, 2015. The return on the trade was 33.00%.
            What is Mark James Litton's role in Alder Biopharmaceuticals?
            Mark James Litton's role in Alder Biopharmaceuticals is CBO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.